METANOVA: A phase II trial of metastasis-directed radiotherapy for de novo oligometastatic prostate cancer treated with long-term androgen deprivation therapy in the STAMPEDE trial.
Year: 2025
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Angela Y. Jia, Joshua Michael Lang, Rohan K. Patel, Himanshu Nagar, Raed Zuhour, Kevin Victor Chaung, Nicholas G. Zaorsky, Prateek Mendiratta, Jonathan E. Shoag, James Robert Janopaul-Naylor, Francesca Khani, Edward M. Schaeffer, Pedro C. Barata, Jason R. Brown, Jorge A. Garcia, Christopher E Barbieri, Yilun Sun, Peter L. Choyke, Daniel Eidelberg Spratt
Institutions: University Hospitals Seidman Cancer Center, Case Western Reserve University, University of Wisconsin–Madison, University of Wisconsin Carbone Cancer Center, Memorial Sloan Kettering Cancer Center, University Hospitals of Cleveland, Case Comprehensive Cancer Center, University Hospitals Cleveland Medical Center, NewYork–Presbyterian Hospital, Weill Cornell Medicine, Northwestern University, National Institutes of Health, National Cancer Institute
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W4410809618